Owner, Antimicrobial Development Specialists, LLC

Patricia A. Bradford is the owner of Antimicrobial Development Specialists LLC, a consulting company that focuses on the late-stage development of antibiotics. Prior to this she worked in the pharmaceutical industry at Lederle Laboratories, Wyeth, Novartis and AstraZeneca and was involved in the successful development, registration and launches of piperacillin-tazobactam, tigecycline and ceftazidime-avibactam. Dr Bradford is fellow in the American Academy of Microbiology and has over 100 publications in peer-reviewed scientific journals. She served as an editor for Antimicrobial Agents Chemotherapy 2001-2011 and is currently a Senior Editor for ASM’s newest journal, mSphere.